nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Furosemide—dilated cardiomyopathy	0.322	1	CbGbCtD
MACITENTAN—EDNRB—cardiac ventricle—dilated cardiomyopathy	0.0373	0.165	CbGeAlD
MACITENTAN—EDNRB—myocardium—dilated cardiomyopathy	0.0351	0.155	CbGeAlD
MACITENTAN—EDNRA—cardiac ventricle—dilated cardiomyopathy	0.0308	0.136	CbGeAlD
MACITENTAN—EDNRA—myocardium—dilated cardiomyopathy	0.029	0.128	CbGeAlD
MACITENTAN—EDNRB—heart—dilated cardiomyopathy	0.0245	0.108	CbGeAlD
MACITENTAN—EDNRB—cardiac atrium—dilated cardiomyopathy	0.0209	0.0927	CbGeAlD
MACITENTAN—EDNRB—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.0205	0.0453	CbGpPWpGaD
MACITENTAN—EDNRA—heart—dilated cardiomyopathy	0.0202	0.0896	CbGeAlD
MACITENTAN—EDNRA—cardiac atrium—dilated cardiomyopathy	0.0173	0.0766	CbGeAlD
MACITENTAN—EDNRA—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.0147	0.0325	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0119	0.0264	CbGpPWpGaD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—dilated cardiomyopathy	0.0119	0.0262	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0111	0.0245	CbGpPWpGaD
MACITENTAN—ALB—heart—dilated cardiomyopathy	0.0107	0.0475	CbGeAlD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0105	0.0231	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00919	0.0203	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00856	0.0189	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00855	0.0189	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00795	0.0176	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—RAC1—dilated cardiomyopathy	0.0077	0.017	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0075	0.0166	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00674	0.0149	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00657	0.0145	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00613	0.0135	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00562	0.0124	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00562	0.0124	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—RAC1—dilated cardiomyopathy	0.00551	0.0122	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00529	0.0117	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00522	0.0115	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—RAF1—dilated cardiomyopathy	0.0051	0.0113	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0044	0.00972	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00438	0.00967	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00432	0.00955	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00409	0.00904	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00402	0.00888	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00402	0.00888	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.00402	0.00888	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00396	0.00875	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00391	0.00865	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00384	0.00849	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00383	0.00846	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00377	0.00833	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00377	0.00833	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00374	0.00826	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—RAF1—dilated cardiomyopathy	0.00365	0.00807	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0035	0.00774	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00348	0.0077	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00339	0.0075	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00338	0.00747	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00332	0.00734	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00321	0.00709	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00315	0.00696	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00313	0.00692	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00309	0.00683	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00308	0.0068	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00304	0.00672	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00296	0.00655	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00293	0.00647	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0029	0.0064	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00287	0.00634	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00287	0.00634	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00283	0.00626	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00282	0.00624	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.0028	0.00619	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00275	0.00608	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00275	0.00607	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0027	0.00596	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0027	0.00596	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00267	0.00589	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00258	0.00571	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00251	0.00554	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00243	0.00537	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00242	0.00535	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0023	0.00507	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00221	0.00488	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0022	0.00487	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00218	0.00481	CbGpPWpGaD
MACITENTAN—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00217	0.00479	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00209	0.00463	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00207	0.00458	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00205	0.00454	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00205	0.00454	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00204	0.00451	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00197	0.00435	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00197	0.00435	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00196	0.00433	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00191	0.00422	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00191	0.00422	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00185	0.00409	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00178	0.00394	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0017	0.00376	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00162	0.00358	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00162	0.00358	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00159	0.00352	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00158	0.00349	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00155	0.00343	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00155	0.00342	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00152	0.00336	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00152	0.00336	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00151	0.00333	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0015	0.00331	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00147	0.00325	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00147	0.00325	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00146	0.00323	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00146	0.00322	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00137	0.00303	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00137	0.00302	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00133	0.00293	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00131	0.0029	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00131	0.0029	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.00127	0.0028	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00127	0.0028	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00125	0.00276	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00121	0.00267	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00121	0.00267	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00118	0.00261	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00117	0.00259	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00116	0.00256	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00116	0.00256	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00113	0.0025	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00111	0.00246	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0011	0.00244	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00108	0.00238	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00107	0.00237	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00105	0.00233	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00105	0.00233	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00105	0.00233	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00105	0.00231	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000991	0.00219	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00098	0.00217	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00098	0.00216	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000949	0.0021	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000938	0.00207	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000919	0.00203	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000918	0.00203	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000893	0.00197	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000878	0.00194	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00087	0.00192	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00087	0.00192	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000847	0.00187	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000834	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000811	0.00179	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000809	0.00179	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000797	0.00176	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000797	0.00176	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000796	0.00176	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000783	0.00173	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000774	0.00171	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000774	0.00171	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000769	0.0017	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000742	0.00164	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000719	0.00159	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000701	0.00155	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000677	0.0015	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000669	0.00148	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000657	0.00145	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000635	0.0014	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000628	0.00139	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000623	0.00138	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000623	0.00138	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000604	0.00133	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000597	0.00132	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000579	0.00128	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00057	0.00126	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000563	0.00124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000561	0.00124	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000553	0.00122	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000545	0.0012	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00053	0.00117	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000523	0.00116	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000493	0.00109	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000492	0.00109	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00048	0.00106	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000479	0.00106	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AGT—dilated cardiomyopathy	0.000471	0.00104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000469	0.00104	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000454	0.001	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000445	0.000982	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000441	0.000975	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000399	0.000882	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000396	0.000875	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00039	0.000862	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000379	0.000838	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000353	0.000779	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000352	0.000777	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.00034	0.000752	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AGT—dilated cardiomyopathy	0.000337	0.000744	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000327	0.000722	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CD36—dilated cardiomyopathy	0.00029	0.000641	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000282	0.000624	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAC1—dilated cardiomyopathy	0.000273	0.000604	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000271	0.0006	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000271	0.000599	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000265	0.000586	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000264	0.000584	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000243	0.000538	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.00024	0.00053	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000238	0.000525	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000237	0.000524	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000234	0.000517	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000224	0.000495	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000213	0.000472	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAF1—dilated cardiomyopathy	0.000181	0.000401	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00016	0.000354	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000157	0.000347	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPX1—dilated cardiomyopathy	0.000121	0.000267	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CD36—dilated cardiomyopathy	0.000118	0.00026	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	0.000108	0.00024	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AGT—dilated cardiomyopathy	0.000106	0.000234	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	0.000106	0.000233	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	9.51e-05	0.00021	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.52e-05	0.000144	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.35e-05	0.00014	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.72e-05	0.000126	CbGpPWpGaD
